A carregar...
How I manage patients with relapsed/refractory diffuse large B cell lymphoma
Despite progress in the upfront treatment of diffuse large B cell lymphoma (DLBCL), patients still experience relapses. Salvage chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard second‐line treatment for relapsed and refractory (R/R) DLBCL. However, half of the pat...
Na minha lista:
| Publicado no: | Br J Haematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175435/ https://ncbi.nlm.nih.gov/pubmed/29808921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|